[Prostaglandins and prostacyclin].
Klockenbusch
W
W
Frauenklinik, Heinrich-Heine-Universität, Düsseldorf.
Schrör
K
K
D000020:Abortifacient Agents, Nonsteroidal / Q000009:adverse effects / Q000627:therapeutic use; D000818:Animals; D002584:Cervix Uteri / Q000187:drug effects; D011464:Epoprostenol / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007751:Labor, Induced; D011225:Pre-Eclampsia / Q000188:drug therapy; D011247:Pregnancy; D011274:Pregnancy, Tubal / Q000188:drug therapy; D011453:Prostaglandins / Q000009:adverse effects / Q000627:therapeutic use*; D014590:Uterine Contraction / Q000187:drug effects; D014593:Uterine Inertia / Q000188:drug therapy
D000020:Abortifacient Agents, Nonsteroidal; D011453:Prostaglandins; D011464:Epoprostenol